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ABSTRACT
The market for non-corporate medical research facilities was
examined to determine if the participation of the private
development industry is warranted. Research funding sources
and their payment policies were described, along with the
activities and priorities of the institutions which house
medical research. A national market overview was provided,
followed by case studies which surveyed the research
components of several institutions and explored how they
have acted to address their space requirements. Financial
analysis was performed on several different occupancy
scenarios to illustrate the varying impacts on institutional
finances.
Some nonprofit institutions which perform medical research
have leased laboratory facilities developed and owned by
private real estate interests. The most likely
institutional candidates for future leasing activity are
those which have little development capacity on their
campuses, are restricted in their access to capital funds,
and have the ability to recover the costs of leasing from
their research sponsors. Present federal policies for
reimbursement of the indirect costs of sponsored research
activities were found to produce financial incentives to the
institution for the participation of an outside developer in
a lease arrangement for laboratory space.
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Chapter I
INTRODUCTION
According to an April 1987 article in the Boston
Business Journal 1, the city's academic medical centers were
finding it difficult to enlarge their biomedical research
capacity. The culprit, reported the BBJ, was the regional
real estate boom of the 1980s, which has constrained the
ability of the medical schools and teaching hospitals to
expand their campuses. Some institutions had decided to
lease offsite research facilities from developers, while
others were very reluctant to do so. The article indicated
that a shortage of expansion space would eventually threaten
the city's preeminent position as a world center of
biomedical research.
This paper will examine issues surrounding the present
and future demand for non-corporate medical research space
and look at the potential role of the private development
industry in supplying that space. First, the major sponsors
of medical research, who provide the funding for the
investigators, will be briefly profiled. An overview of
funding trends ;.ill be provided, as will an attempt to
predict future patterns of support. Then, the performers of
research, who consume the sponsors' funding, will be
examined, with particular emphasis on the role of the
academic medical centers. A discussion of the
characteristics of a research facility will be followed by
an overview of the national and regional development climate
related to medical research. Then a group of case studies
will describe how Boston's medical schools and teaching
hospitals have dealt with their research space needs. A
series of financial analyses will show how federal
reimbursement policies can impact institutional capital
decisions. The paper will conclude with some observations
and lessons for developers drawn from the case studies.
NOTES
1. Denaro, Deborah and Gendron, Marie
"Hospitals hurting for space"
The Boston Business Journal, p. 1, April 6, 1987
Chapter II
WHAT IS BIOMEDICAL RESEARCH?
Biomedical research involves the development of new
diagnostic and therapeutic modes, advancement of medical
technology, and improvement of drug therapy. Research
activities increase understanding of disease processes and
their prevention or alleviation, and include investigation
into improved systems of health care delivery. Research
activities can be conveniently divided into two types: one
asks "what if" and the other "how to". "What if", or
"basic" research, typically is conducted with no
presuppositions about its relevance to a clinical problem.
"How to", or "applied" research, seeks to create or improve
a technique or an apparatus to achieve a predetermined end
Biomedical research and development in the U.S. is
conducted in several different arenas: in university science
departments; in privately-funded charitable research
institutions (such as the Howard Hughes Medical Institute);
in the laboratories of commercial pharmaceutical companies;
at the National Institutes of Health (NIH) in Bethesda,
Maryland; and in the nation's medical schools and teaching
hospitals. This paper focuses on the latter venue.
NOTES
1. Fudenburg, H. Hugh, ed.
Biomedical Institutions, Biomedical Funding, and
Public Policy, Chapter 2 New York: Plenum Press. 1983
Chapter III
WHO PAYS FOR BIOMEDICAL RESEARCH?
Table 1 below traces national support for health
research and development over the decade 1976-1986. As part
A of the table shows, the federal government, substantially
through the National Institutes of Health, remains the
largest source of funds for health R & D, providing about
half of total support in 1986. The last decade has seen
private industry's share of funding increase dramatically as
a percentage of total support. By 1986 nearly 40% of all
health R & D funds came from private industry, compared to
less than 30% just ten years earlier. State and local
governments have provided a consistent percentage of
funding, while support from private philanthropies has
declined to less than 5% of the total.
The broad mission of the National Institutes of Health
is to "promote the well-being of citizens" by encouraging
and supporting research that will lead to medical
innovations. The 11 institutes of the NIH fall under the
aegis of the Department of Health and Human Services (HHS),
and are financed through a direct appropriation of public
funds by the Congress . About 12% of the NIH budget is
spent on intramural research programs conducted on the
Bethesda campus. NIH activities are structured around four
major classifications: basic research, clinical application,
technology transfer, and training of scientists. The NIH
has been the mainstay of basic medical research support
Sector 1978 1980 1982 1984 1985 1986
prel. est. proj.
Total of A or 8 5107 $6,264 $7,924 $9,303 $11,619 $13,106 $14,348
A. BY SOURCE OF FUNDS
Government 3371 66.0% 4,182 66.8% 5,145 64.9% 5,528 59.44 6,769 58.3% 7,604 58.04 8,085 56.3%
NIH 2060 40.3% 2,581 41.2% 3,182 40.2% 3,433 36.9% 4,257 36.6% 4,828 36.8% 4,977 34.7%
Other Federal 999 19.6% 1,230 19.6% 1,541 19.4% 1,537 16.54 1,830 15.8% 1,980 15.14 2,197 15.3%
State & Local 312 6.1% 371 5.9% 422 5.3% 558 6.04 682 5.9% 796 6.1% 911 6.3%
Industry 1469 28.8% 1,800 28.7% 2,466 31.14 3,436 36.9% 4,378 37.74 4,975 38.04 5,638 39.3%
Private Philanthropies 267 5.2% 282 4.5% 313 4.04 339 3.6% 472 4.1% 527 4.0% 625 4.44
B. BY PERFORMER
Government 904 17.7% 1,163 18.6% 1,439 18.2% 1,595 17.1% 1,901 16.4% 2,115 16.1% 2,226 15.5%
Federal 780 15.3% 1,032 16.5% 1,284 16.2% 1,448 15.6% 1,741 15.04 1,943 14.8% 2,048 14.3%
State & Local 124 2.4% 131 2.1% 155 2.0% 147 1.6% 160 1.44 172 1.3% 178 1.2%
Industry 1483 29.04 1,680 26.8% 2,256 28.5% 3,016 32.4% 3,855 33.2% 4,332 33.14 4,841 33.74
Private Nonprofit 2461 48.2% 3,084 49.2% 3,728 47.0% 4,107 44.1% 5,180 44.6% 5,862 44.7% 6,359 44.3%
Higher Education 1945 38.14 2,445 39.04 2,987 37.7% 3,319 35.7% 4,149 35.7% 4,695 35.8% 5,062 35.3%
Other 516 10.14 639 10.2% 741 9.4% 788 8.54 1,031 8.94 1,167 8.9% 1,297 9.0%
Foreign 259 5.14 337 5.4% 501 6.3% 585 6.3% 683 5.9% 797 6.1% 922 6.4%
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since the Second World, War. Approximately 60% of NIH
expenditures support basic research. Other important
federal funding sources for health R & D include the Public
Health Service, the Departments of Defense, Energy, and
2Agriculture, the Veterans Administration, and NASA
Part B of Table 1 shows where the funds from Part A
were spent. Private industry is now consuming over a third
of all health R & D funds. The federal government remains
an important research performer. The share of funds flowing
to private educational institutions has declined slightly in
the decade.
About half of these federal health R & D funds are
awarded to institutions of higher education. One third is
spent within federal research agencies, and the remainder
goes to other nonprofit institutions or to industry.
The commercial pharmaceutical and biotechnology
industries spend about 95% of their R & D funds in their own
laboratories, although this percentage will very likely
decline as universities and hospitals become more willing to
collaborate with industry 3. The commercial firms, who must
achieve a return on investment for their shareholders,
perform relatively little basic research, concentrating
instead on applying research to marketable products or
processes.
Other research funds are disbursed by charities such as
the Robert Wood Johnson Foundation and the American Cancer
Society. Some choose to spend their money internally on
their own research efforts, while others simply provide
grants to university-based investigators, or donate funds
for laboratory construction. Unfettered by the needs of
stockholders, many philanthropic institutions choose to
support the basic medical research that industry cannot
cost-justify.
NOTES
1. Fudenberg, op. cit., Chapter 6
2. National Institutes of Health
"The NIH Data Book 1986", Bethesda, 1987
3. Fudenberg, op. cit., Chapter 6
Chapter IV
THE FUTURE OF RESEARCH FUNDING
Because the scientific community, particularly that
segment which conducts basic research, depends so heavily on
the federal dollar, considerable hand-wringing occurs every
year as the Administration proposes the federal budget and
the Congress acts upon it. The Reagan Administration's
Office of Management and Budget (OMB) has been particularly
active in attempting to restrain health research funding and
increase military R & D. Military research, if funded as
proposed by the Administration, would consume 72% of total
government R & D outlays in FY 1988, up from 50% when Reagan
1
took office . The Congress, however, has a long record of
magnanimity towards the NIH. A news account of the NIH
director's yearly budget presentation before the Senate
appropriations subcommittee in 1986 concluded:
Thus went the annual ritual in which the
Administration proposes a pa5 simonious budget for NIH
and Congress ups the request
Sure enough, when the budget for FY 1987 was passed,
the NIH had ended up with a 17% increase over FY 1986,
almost $1.2 billion more than the Administration had
3
proposed . Some of these funds will be cut when the
Gramm-Rudman deficit control measures automatically take
effect, but the increase will remain very generous compared
with funding for other research agencies. Also in 1986, OMB
attempted to place a cap on reimbursement for indirect
administrative costs on federal research grants, but the
4
science community was able to postpone this action .
As of this writing, FY 1988 funding is being debated,
with the Administration once again proposing significant
increases in military research programs, and the Congress
likely to shift some of those increases to biomedical
5
research5. The escalating battle to find a cure for AIDS
will also surely demand incremental federal research
funding. In the future, despite the realities of the
federal deficit, one can imagine in the future a less
defense-oriented administration favoring biomedical R & D
over military research.
University and hospital research administrators
interviewed for this paper were quite optimistic about the
prospects for federal support of biomedical research. Even
those who did not anticipate real increases in federal
support were confident that their institutions would be able
to garner an increased proportion of the federal pie because
of the superior qualifications of their investigators.
Nearly all the administrators suggested that the recent
trend of greater support from industry would continue or
even accelerate. Although in 1986 only about 5% of industry
R & D outlays went to contracts with universities or
hospitals, some institutions were receiving significant
volumes of funding. Massachusetts General Hospital, for
example, received 18% of its $75 million 1986 research
6budget from commercial contracts .A July 1987 article in
16
Fortune magazine described the fledgling biotechnology
industry's reliance on R & D, and mentioned an agreement
between Johnson & Johnson and the Scripps Clinic and
Research Foundation. The agreement gives the big
pharmaceutical firm first refusal for the rights to any
commercial application of Scripps' health care research, in
7return for financial support . Boston's Brigham & Womens
Hospital recently hired a Vice President whose focus is to
cultivate and expand alliances with industry. As part of
her duties, she will negotiate licensing and research
contracts for hospital investigators
Another encouraging development for medical research is
the increased support by the Howard Hughes Medical Institute
(HHMI). Since the sale of Hughes Aircraft in 1985, the
Institute has embarked on a massive expansion of its
research laboratories. Hughes investigators now operate in
27 hospital- and university-affiliated labs around the
country, with an annual budget in excess of $200 million and
9growing . Prior to the Hughes expansion, funding from
philanthropic sources had grown at a much slower rate than
10federal and industry support
While it is certainly difficult to predict future
levels of biomedical research support, it seems that those
institutions who house research activities can be relatively
confident that they are insulated against substantial
cutbacks in funding. The Congress has long considered the
support of health research, particularly basic research, to
be an important public policy. Industry is on the verge of
achieving many significant breakthroughs and will continue
to look to R & D to provide the needed competitive edge.
Finally, private philanthropies are likely to maintain a
fairly constant level of financial support for research
performers.
NOTES
1. Norman, Colin
"Budget Details Released"
Science, Vol. 235, p. 628, January 23, 1987
2. Norman, Colin
"NIH Gets a Friendly Hearing on Capitol Hill"
Science, Vol. 231, March 21, 1986
3. Culliton, Barbara
"Congress Boosts NIH Budget 17.3%"
Science, Vol. 234, p. 808, November 14, 1986
4. Association of American Medical Colleges
"1985-1986 Annual Report"
Journal of Medical Education, Vol. 62, #3, Mar 1987
5. Culliton, Barbara, op. cit.
6. Conversation with Lawrence Martin
Associate General Director, Mass. General Hospital
July 9, 1987
7. Gannes, Stuart
"The Big Boys Are Joining The Biotech Party"
Fortune, July 6, 1987
8. "BWH researchers find industry can be a valuable ally"
Boston Hospital News, April 1986, p. 32
9. Culliton, Barbara
"Hughes Settles with IRS"
Science, Vol. 235, p. 1318
10. "The NIH Data Book 1986", op. cit.
Chapter V
WHO PERFORMS BIOMEDICAL RESEARCH?
Most federal grants for medical research are
"investigator-initiated". That is, they are awarded to a
scientist or physician who has proposed a specific study.
The proposal undergoes rigorous peer review to verify its
scientific and technical merit. Investigators usually have
an institutional affiliation such as a faculty or clinical
appointment at an academic medical center or employment at a
corporation or research institute. Grants are awarded to
the investigator in the name of the institution. The
institution houses the research activity, and is reimbursed
for its related costs by the sponsoring agency.
Under 10% of NIH funding goes to research contracts,
whereby the sponsoring agency decides the scope and
1direction of the investigation in advance . Ten years ago,
this percentage was significantly higher, but the scientific
community has persuaded the Congress that investigator-
initiated research is a better use of the federal dollar.
Industry-funded research is usually directed by
strategists within the corporation. That which is not
performed by employees of the firms is contracted out to
university- or hospital-based investigators. Many of the
commercial firms, however, set aside some of their R & D
budgets for basic research in their own labs.
NOTES
1. "The NIH Data Book 1986", op. cit.
Chapter VI
THE ACADEMIC MEDICAL CENTERS
Academic medical centers are integrated units
comprising a medical school and one or more additional
health education programs and associated teaching hospitals.
The center's role is fourfold: it is the principal place for
educating physicians, dentists, nurses, pharmacists, and
other health care professionals; it provides technologically
advanced or complex medical treatment not available in
community hospitals; it is the chief source of primary care
for the uninsured and economically disadvantaged in the
inner cities; and it plays a unique role in medical research
and in the application of that research to new diagnostic
and therapeutic techniques .
There are 126 accredited institutions offering degrees
in medicine in the United States. Of the 6000 or so
hospitals in the country, 430 are members of the Council of
Teaching Hospitals (COTH) of the American Association of
2
Medical Colleges2. Although hundreds of other hospitals
have residency programs and assist in the training of
physicians, COTH members are the major teaching affiliates
of the medical schools. Their distinguishing characteristic
is a three-legged commitment to patient care, medical
education, and research. Indeed, virtually all clinical
investigation (research directly applicable to patient care)
is performed in these teaching hospitals.
Medical schools, which are units of universities or
university systems, receive their income from a variety of
sources, including tuition and fees, grants and contracts,
patient care reimbursement from the faculty medical practice
plan, gifts, endowment earnings, and government subsidy3
Independent teaching hospitals, like all hospitals,
generate most of their income through their patient care
activities. Third-party payors such as Medicare/Medicaid
and the private health insurance carriers provide most of
the reimbursement. The recent switch by these payors from
retrospective payment, where the hospital recovers all of
its expenses, to prospective payment (PPS), where the
reimbursement is stipulated in advance based on national
cost standards, has forced hospitals to be much more
cost-conscious in their behavior. Additionally, PPS has
drastically reduced the average length-of-stay for patients,
producing a glut of hospital beds and generating intense
4competition between hospitals for patients
Teaching hospitals, with higher than average cost
structures, were hard hit by the switch to national
standards. Reimbursement to the hospitals for their
indirect costs related to graduate medical education is now
likely to be fixed at low rates, partially to restrain the
system from producing too many physicians. Furthermore,
patient care income from third-party payors cannot be used
for research funding. From a financial standpoint, the
research function of a teaching hospital is intended to
stand apart from the patient care and teaching functions5.
21
NOTES
1. Stark, Nathan J.
"Academic health centers: an uncertain future"
Hospitals, August 20, 1986, p. 104
2. American Medical Association
"Survey of Teaching Hospitals 1985"
JAMA, Journal of American Medical Association,
September 26, 1986
3. Eastaugh, Steven R.
Medical Economics and Health Finance, Ch. 11
Boston: Auburn House. 1981
4. Conversation with Professor Gerard Wedig
Boston University School of Management
June 30, 1987
5. Conversation with David Shabot
Massachusetts Hospital Association
June 16, 1987
Chapter VII
THE ROLE OF RESEARCH IN THE ACADEMIC MEDICAL CENTERS
Like their colleagues in other sectors of academia,
medical educators are expected to engage in research
activities as part of their professional responsibilities.
Such research, it is hoped, will add to the body of
scientific knowledge, while enhancing the skills of the
investigator and his or her students. Furthermore,
publication of research findings will bring recognition,
from peers and perhaps from the public, to the investigator
and to the institution.
It is widely held in the academic medical community
that the presence of a research function enhances the
quality of care available to patients. Competition is keen
among the hospitals as they seek to attract and retain noted
physicians and researchers, who will in turn attract
patients seeking the best of medical care. The sentiment
expressed in the following statement, from a recent hospital
master plan, is typical:
In order to maintain its position on the
leading edge of medical innovation, and to retain
and attract highly qualified clinical faculty, the
Hospital must develop a teaching and research
reputation comparable to its jeputation for
providing outstanding clinical care
NOTES
1. M. Bostin Associates, Payette Associates
"Master Plan for New England Deaconess Hospital"
Submitted to Boston Redevelopment Authority, May 1987
Chapter VIII
HOW THE MEDICAL CENTERS GET PAID FOR DOING RESEARCH
Since the federal government is the financial sponsor
for the majority of non-commercial biomedical research, the
method of reimbursement established by the Office of
Management and Budget (OMB) is extremely important to the
hospitals and medical schools . The federal government is
known as a "full" or "100%" reimburser. That is, OMB
recognizes all direct and indirect costs associated with
each research grant, and allows the supporting institution
to be reimbursed for those costs. Calculation of direct
costs related to sponsored agreements is straightforward.
However, the definition of indirect costs, and the method
for allocating those costs, has important implications for
capital decisions related to research space.
Direct Costs
Direct costs are those costs identified specifically
with a particular sponsored project, including compensation
and fringe benefits of employees assigned to the project,
cost of materials and supplies used in the research,
services and travel costs incurred, and costs of subgrants
and subcontracts related to the project. The grant
applicant estimates the direct costs of the investigation.
The sponsoring agency either approves or adjusts the
requested amount. Direct cost expenditures in excess of the
amount awarded are not recoverable from the sponsor.
24
Indirect Costs
Indirect costs are those costs that are incurred for
common or joint objectives and which therefore cannot be
identified readily and specifically with a particular
sponsored activity. These costs include depreciation and
use allowances, operation and maintenance expenses, and
various administrative expenses. After awarding an amount
for direct costs of an investigation, the sponsoring agency
adds on an indirect cost award based on the indirect cost
rate used by the institution at which the grant will be
performed.
The Indirect Cost Rate
The indirect cost rate applicable to the research
function of a teaching hospital or medical school is
re-established annually. The rate, usually expressed as a
percentage of the total direct costs, is calculated prior to
the start of the fiscal year by the institution. An auditor
from the cognizant agency (different federal agencies are
assigned to monitor different grantee institutions: for
example; M.I.T. is monitored by the Department of Defense;
HHS monitors hospitals) will assure that OMB guidelines have
been adhered to. At the end of the year, after actual
allowable costs are known, the rate is recalculated. If the
sponsoring agency over- or under-reimbursed the grantee
institution, the subsequent year's rate would be set
artificially low or high to balance the payments.
25
Depreciation Allowance
Institutions are compensated for the use of their
buildings and equipment in sponsored agreements through a
depreciation allowance, which is calculated into the
indirect cost rate. The computation for the depreciation
allowance is based on the acquisition cost of the asset, not
including cost of the land. The asset is then depreciated
on a straight-line basis over its useful life. Typically,
building shells are depreciated over 40 years; interior
building fixtures and finishes over 20 years; and major
movable equipment over an average of about 8 years.
Rental Costs
Rental costs of buildings and equipment are allowable
in full as indirect costs for both hospitals and educational
institutions, provided that the lease is a prudent,
"arms-length" transaction, and does not create a "material
equity" in the property for the institution. A material
equity exists when the lease:
(1) is noncancelable, and
(2) has one or more of the following characteristics:
(a) Title to the property passes to the institution at
some time during or after the lease period.
(b) The term of the lease corresponds substantially to
the estimated useful life of the property.
(c) The initial term is less than the useful life of the
property and the institution has the option to renew
the lease for the remaining useful life at
substantially less than fair rental value.
(d) The property was acquired by the lessor to meet the
special needs of the institution and will probably
only be usable for that purpose and only by the
institution.
(e) The lease has a bargain purchase option.
A lease which creates a material equity is considered to be
a "capital" lease, essentially an installment purchase.
Rental costs for a capital lease are reimbursable only to
the amount allowed had the institution purchased the asset
on the date the lease was signed. Similarly, rental costs
on "sale and lease-back" arrangements are reimbursable only
to the amount allowed had the institution continued to own
the property.
Assignment of Indirect Costs
Institutions are allowed some flexibility in
determining their indirect cost rate. Since indirect costs
can vary substantially between different facilities in the
same institution, separate indirect cost pools might be
established for each facility. For example, New England
Deaconess Hospital might have differing indirect cost pools
for its Cancer Research Institute, its Shields-Warren
Research Building, and its leased facilities on Burlington
Street. A possible budgeted reimbursement scenario for the
three facilities is shown below.
MODIFIED INDIRECT TOTAL
TOTAL COST FEDERAL
DIRECT RATE REIMBURSE-
COSTS MENT
Cancer Research
Institute $2,000,000 52% $3,040,000
Shields-Warren
Building 1,000,000 55% 1,550,000
Burlington St.
Labs 2,000,000 60% 3,200,000
Totals $5,000,000 $7,754,000
Note that if an unbudgeted award caused the Cancer Research
Institute's direct costs to increase by $500,000, the
indirect cost reimbursement would increase by $260,000
($500,000 x .52). Actual indirect costs would increase only
slightly, however, resulting in an overpayment that would
have to be adjusted for in the following year's rate.
An alternative technique for the hospital would be to
have all its indirect research costs reimbursed at the same
rate, based on the total direct and indirect costs for the
institution.
Interest Expense Reimbursement
An important distinction between hospitals and
educational institutions is made in the reimbursement
regulations published and enforced by OMB. Traditionally,
federal sponsors did not allow interest expense to be
included as part of indirect cost reimbursement. In 1982,
educational institutions, including medical schools,
succeeded in having their cost principles (OMB Circular
A-21) revised Following the revision, educational
institutions would be reimbursed for the costs of financing
new buildings, remodelings, or capital equipment, "provided
the total cost (including depreciation or use allowance,
operation and maintenance costs, interest, etc.), does not
exceed the rental cost of comparable assets in the same
locality". Hospitals and other research performers not
owned by educational institutions received no such revision
to their regulations.
28
Deviation from Interest Expense Exclusion
Recently, a few hospitals have received reimbursement
for interest expense after enduring a "deviation procedure".
The hospital must persuade the cognizant auditor that it is
in the government's best interest to reimburse the
3institution for financing costs3. Because no regulations
are in place to guide the auditors in their decision-making,
and since there are only a small number of precedents, it
would be unwise of any hospital to commit to debt financing
before going through the deviation procedure and securing an
agreement from the government to reimburse interest costs.
Reimbursement Policies For Other Funding Sources
Funding sources which are not federal grants may have
widely differing reimbursement methods. Federal contracts,
for example, might be awarded on a bid basis and carry a
predetermined indirect cost payment rate. Commercial
contracts are negotiated between the parties. In the past,
industry had been willing to pay only the direct costs of
research they sponsored at institutions. Nowadays, most
research performers seek to be fully reimbursed for direct
and indirect costs, usually at the federal rate. Funds from
foundations or gifts may be unrestricted or might have very
specific use stipulations. Institutions with a superior
research reputation are able to negotiate more favorable
reimbursement arrangements from non-federal supporters.
29
NOTES
1. Office of Management and Budget
"Circular A-21--Cost Principles for Educational
Institutions"
Federal Register, Vol. 44, No. 45, March 6, 1979
2. Office of Management and Budget
"Circular A-21--Cost Principles for Educational
Institutions"
Federal Register, Vol. 47, No. 149, August 3, 1982
3. Conversation with Walter Boland
Office of the Regional Director of Department of
Health and Human Services
July 14, 1987
Chapter IX
THE MEDICAL RESEARCH FACILITY
The editor of a recent text on laboratory design stated
that three key issues must be responded to in the design
1process . First, flexibility must be achieved, to the
extent possible, because of the unpredictable changes in
needs which will occur over the life of the facility.
Second, the building occupants and the surrounding community
must be protected from the explosive, toxic, or otherwise
hazardous materials which may be present in the facility.
Finally, providing a quality work environment for the
occupants will greatly aid the institution in attracting and
retaining scientific personnel. These challenges are as
true for retrofitted facilities as for new construction.
Because of the complexity of this building type, a developer
must be certain to hire professionals and consultants with
experience in laboratory design.
The basic laboratory module, with its ergonomically
appropriate dimensions, has become fairly standardized over
time. Figures 1 and 2 below show the generic module in
plan, elevation, and isometric. A 20- to 24- foot wide bay
contains benches, desks, shelves, work sinks, and one or
more fume hoods for up to four investigators. Current
research practice favors an open plan whereby laboratories
open directly to adjacent labs and to corridors where
researchers share equipment and support rooms. This concept
facilitates a high degree of interaction among individual
FIGURE 1
Generic laboratory plan
large
Generic laboratory elevation
Source: The Children's Hospital Facilities Planning Office
Research Expansion Update, June 1987
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researchers. The corridors become extensions of the
workspaces and allow for informal contact between members of
different research groups .
The evolution in lab design is depicted in Figure 3,
the plan for the Enders Research Building at Children's
Hospital in Boston. The original building, completed in
1970, is at the left of the plan, and has closed lab modules
and limited support facilities and offices. The expansion
of the Enders Building, to be completed in 1990, shows the
open lab concept, as well as the extensive support space
demanded by today's research activities. Massachusetts
General Hospital employed the open plan in the Wellman
Building, completed in 1984, and in the Charlestown Labs
under construction as of this writing. Floor plans for
these two buildings are shown at the same scale in Figure 4,
dramatizing the huge size (180' x 440') of the Charlestown
floor plate. Figure 5 shows a typical floor at the Tupper
Research Institute at New England Medical Center in Boston.
Once again, open labs line much of the building perimeter,
here on a very small (7500 square feet) floor plate.
The single most important distinction between lab space
and other building typologies is the quantity of mechanical
services provided. The engineering is especially
challenging when a building is being retrofitted from a
different use. One architect estimated that 70% of the
design work in a retrofit project is in the engineering. He
even suggested that it might be appropriate to designate the
FIGURE 3
Generic laboratory floor plan
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Equipment and support zone
Laboratory zone
Offices
mechanical engineering firm as the lead design consultant,
with the architect in the subcontractor position.
Because of the many mandatory functional and safety
criteria governing lab design, there are few opportunities
for cost cutting. Compromises in the quality of
environmental systems may lower the cost of construction,
but will add to life cycle costs and could jeopardize the
safety of the occupants and the facility's neighbors3
Some of the special design components include: an
elaborate air-handling system to exhaust fumes or maintain
positive or negative air pressures (when fume hoods are in
operation, labs can require 15-25 air changes per hour; a
typical office use demands 1-2 air changes per hour); heavy
electrical including emergency power generators for
refrigeration equipment; neutralization or sterilization
systems for laboratory waste liquids; dry sprinkler systems
for cold rooms or freezers; explosion- or radiation-proof
rooms; vibration-isolated facilities for electron
microscopes; and facilities for washing and sterilizing lab
4
glassware .
One of the most expensive and stringently regulated
components of a medical research facility is the Animal
Room. Laboratory animals require tightly controlled
atmospheric conditions, filtered air exhaust, and special
water and drainage systems.
Additionally, each lab bench is typically serviced by
hot and cold tap water, distilled water, natural gas,
compressed air, and sometimes vacuum air systems. Lab
support facilities include warm rooms, cold rooms, dark
rooms, and computer rooms.
Office space for the principal investigators and
departmental support staff is provided on each floor,
adjacent to the labs themselves. The quality and quantity
of this space will depend on institutional priorities.
Developers who intend to produce medical research space
must recognize the complexity of the facility. The
selection of professionals with laboratory design experience
is a must. Extra design time must be built into the
development process to assure that regulatory, safety, and
operational issues are adequately addressed.
NOTES
1. Braybrooke, Susan, ed.
Design for Research--Principles of Laboratory
Architecture, Preface
John Wiley & Sons, New York 1986
2. Ellenzweig, Moore and Associates, Inc., Architects
Brochure for Earl S. Tupper Research Institute, 1986
3. Braybrooke, op. cit., Chapter 3
4. Braybrooke, op. cit., Chapter 4
Chapter X
NATIONAL ACTIVITY
Across the country, the development of new medical
research space continues to be performed by the institutions
who will occupy the facilities. Universities and hospitals
are actively producing or planning new space in order to be
more competitive for research funding. There are
indications that locational constraints and/or financial
conditions may cause institutions to seek the services of
the private development community to help with their future
expansion.
Modern Healthcare magazine's 1987 poll of architects
and construction firms tallied 41 completions and 42 starts
of medical research facilities in 1986. Briefly mentioned
in the accompanying article were research parks planned by
Johns Hopkins Hospital and the Mayo Clinic . Hospitals
magazine ran an article at the same time indicating that the
medical R & D industry is "going bonkers from coast to
coast" 2 . Buildings planned or underway include a 300,000
square foot facility for Johns Hopkins University in
Baltimore, the Institute for Advanced Biomedical Research at
Oregon Health Sciences University in Portland, and the Human
Biology Research Facility at the University of Iowa in Iowa
City.
A number of urban medical centers contacted for this
paper indicated that research space was at a premium. A
common solution was to relocate administrative functions
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away from the medical center and convert the vacated office
space into labs. Columbia/ Presbyterian Medical Center in
New York has considered some lease opportunities but will
probably purchase a building off-campus. New York
Hospital/Cornell Medical Center has expanded by densifying
its campus. The old-style pavilions and courtyards are
being filled in to increase the floor area.
In Philadelphia, Children's Hospital and the University
of Pennsylvania Medical School have each leased research
space on occasion from the University City Science Center.
UCSC is a 20-year-old non-profit R & D park owned by several
area educational institutions. Since it abuts the Penn
campus, the park is fairly convenient for Medical School
researchers. Rather than taking additional leased space,
however, the hospital will devote two floors of its new
ambulatory care facility to research space, while Penn is
constructing a major laboratory building on campus.
Other institutions, like U.C.L.A. Medical Center, are
able to occupy adjacent underutilized public buildings (in
this case, a former Army hospital owned by the county).
Because administrators there saw little chance of assistance
from the state legislature, U.C.L.A. hopes to fund a new $50
million medical research building with contributions. A
gift campaign is underway. The University of California at
San Francisco Medical Center is in a more difficult
situation. The institution continues to honor a decade-old
commitment to the surrounding neighborhood not to increase
the density of its campus. Several hundred thousand square
feet of administrative space has been moved to off-campus
locations and replaced with research facilities. At this
writing, the Medical Center, which is the second largest NIH
grantee in the nation, is litigating its right to convert a
300,000 square foot office building to research space.
U.C.S.F.M.C. has purchased the building, which is one mile
from campus, but has been blocked from moving forward by
community groups. Robert Ryan of the Office of Resource
Management at U.C.S.F. said that leasing research facilities
could well be an attractive alternative.
At least one national developer has announced its
intention to develop build-to-suit facilities for lease to
academic medical centers. According to Judy Glos, managing
partner of Tishman-Speyer/Mediq, research buildings are just
one of several types of specialty facilities the firm will
offer to construct and own for medical centers.
Tishman-Speyer/Mediq was formed in 1987 by Tishman-
Speyer, a long-standing New York-based builder, developer,
and manager of Class A office buildings, and Mediq,
Incorporated, a New Jersey-based multi-line provider of
services to hospitals. The firm is confident that it can
save medical centers a great deal of time and money in the
development of research facilities. Ms. Glos cites
Tishman-Speyer's excellent track record in bringing major
development projects in on-time and under-budget, and
Mediq's expertise in medical building design. The major
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obstacle the firm has faced thus far, she added, is a lack
of understanding of how to proceed on the part of medical
center administrators. Because the concept of leasing major
facilities has not been tested in the health care industry,
she acknowledges that her challenge is to educate
administrators about the advantages of leasing.
At the University of Maryland Medical School, planning
is underway for a 415,000 square foot research facility
which will likely cost in excess of $100 million. Vice Dean
Dr. Marjorie Wilson favors engaging a national developer
like Tishman-Speyer/Mediq to build the facility and lease it
back to the School for at least 20 years. She estimates
that several years and up to $35 million could be saved by
circumventing the extremely lengthy state capital budgeting
process.
For a facility of the type that University of Maryland
wishes to build, a long-term lease contract could be
structured similar to turn-key contracts for headquarters
office buildings or industrial plants. The lease rate would
be set upon completion of schematics, allowing for an
extensive level of user input into the design. For the base
lease amount, which in effect is a guaranteed maximum price
contract, the institution is provided with "finished shell"
space. All systems, utilities, floor, wall, and ceiling
coverings, and lighting would be in place, awaiting only the
movable lab equipment and the more specialized instruments.
The length of the lease would be partially decided by
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regulations governing operating leases vs. capital (or
financing) leases.
In some parts of the country, communities are
attempting to leverage economic development off of a medical
research infrastructure. Nature magazine described the
efforts of Montgomery County, Maryland, to attract
biotechnology companies by taking advantage of existing
research activities in the area. With the University of
Maryland, the NIH, and several other federal research
agencies already in place, the county hopes to compete with
the San Francisco Bay area and the Boston area .
Montgomery County's prototype might be the
Massachusetts Biotechnology Research Park, located in
Worcester. Adjacent to the University of Massachusetts
Medical Center, the park sits on 75 acres and is programmed
for over a million square feet of space. MBRP is owned by a
non-profit economic development corporation supported by the
City of Worcester. Director Ray Quinlan said the park is
not intended to satisfy the space needs of the Medical
Center. Rather, it is targeted towards the growing biotech
firms that are seeking low-cost space with immediate access
to a thriving academic community. Quinlan can offer
research space at half the cost of Boston space because of
the low-rise, non-union construction, subsidized land (it
was surplus to a state hospital), and low taxes. At this
writing, the first 75,000 square-foot research building is
nearly fully occupied the second is under construction.
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Locational constraints on expansion are particularly
prevalent among many older institutions in dense urban
areas. Such institutions are found in abundance in Boston.
Their solutions to the expansion problem is illustrative for
developers seeking to service a need for research space
production. The case studies in the following chapter will
examine those solutions.
NOTES
1. "Construction/Architects Survey"
Modern Healthcare, February 27, 1987
2. Cherskov, Myk
"Research and development facilities attract money"
Hospitals, February 20, 1987, p. 62
3. "Research centre gets fixed home"
Nature, Vol. 324, p. 400, December 4, 1986
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Chapter XI
CASE STUDIES IN THE BOSTON MARKET
The cities of Boston and Cambridge form one of the
premier centers in the world for medical care, medical
education, and medical research. Many of the region's
hospitals are internationally acclaimed. Table 2 lists
Boston's major teaching hospitals and gives a sense of their
impact on the regional economy. Harvard, Tufts, and Boston
University house their medical schools in the city. The NIH
awarded more than 10% of its 1985 research grants to
Boston-based universities, hospitals, and research
institutes. Table 3 ranks the city's institutions by NIH
grant volume. As shown in Table 4, the state of
Massachusetts ranks third in the country in total NIH
awards. When viewed locally, metropolitan Boston has the
second-highest concentration of health R & D funding in the
country, after New York City. The region also is home to
over two dozen firms specializing in biotechnology,
including several of the leaders of this nascent industry.
Throughout the 1980s, the region has also been one of
the strongest markets in the country for both commercial and
residential real estate. This boom, when coupled with the
anti-growth activities of tenant-advocacy groups and a
prediliction towards downzoning on the part of city
development agencies, has constrained the ability of some
institutions to expand on their urban campuses. The
following cases describe how several of the city's
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institutions have dealt with the need to expand their
research capacity in the face of this difficult real estate
market.
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TABLE 2
BOSTON'S TEACHING HOSPITALS
RANKED BY 1985 TOTAL EXPENSES
PATIENT EXPENSES EMPLOYEES
E OWNERSHIP BEDS (millions) (FTEs)
1. Massachusetts General Hospital
Gen'l Medical Private Non-Profit
2. Brigham & Womens Hospital
Gen'l Medical Private Non-Profit
3. Childrens Hospital Medical Center
Pediatric Private Non-Profit
4. New England Medical Center
Gen'l Medical Private Non-Profit
5. Beth Israel Hospital
Gen'l Medical Private Non-Profit
6. New England Deaconess Hospital
Gen'l Medical Private Non-Profit
7. University Hospital
Gen'l Medical Private Non-Profit
8. St. Elizabeth's Hospital
Gen'l Medical Church-Operated
9. Veterans Administration Medical Center
Gen'l Medical VA-Operated
10. Carney Hospital
Gen'l Medical Church-Operated
11. Mt. Auburn Hospital (Cambridge)
Gen'l Medical Private Non-Profit
12. Massachusetts Eye & Ear Infirmary
Specialty Private Non-Profit
13. Dana-Farber Cancer Institute
Specialty Private Non-Profit
14. Faulkner Hospital
Gen'l Medical Private Non-Profit
15. New England Baptist Hospital
Gen'l Medical Private Non-Profit
Boston City Hospital
Gen'l Medical City-Operated
TOTALS #1 - 15
1082 $ 296.8 6085
720 241.0
339
416
449
489
379
385
4760
166.9 3277
155.3 2457
154.9 3481
120.1 2433
88.7 1455
87.0 1847
691 79.2 1650
422 66.9 1541
305 62.5 1311
60.1 1029
57 59.2 1077
259 44.6 939
96544.6
393 N/A N/A
6,412 $1,727.8 34,307
Source: American Hospital Association
AHA Guide to the Healthcare Field 1986
Thomas J. Andrews 1987
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TABLE 3
BOSTON AREA RESEARCH INSTITUTIONS
1985 RESEARCH GRANTS FROM NATIONAL INSTITUTES OF HEALTH
Harvard Medical School $ 56,700,000
Massachusetts Institute of Technology 42,300,000
Brigham & Womens Hospital 33,800,000
Boston University School of Medicine 31,900,000
Massachusetts General Hospital 29,200,000
Dana-Farber Cancer Institute 25,300,000
Childrens Hospital 18,800,000
Tufts University School of Medicine 17,900,000
Harvard University 12,900,000
Beth Israel Hospital 9,600,000
New England Medical Center 8,800,000
Eye Research Institute--Retina Foundation 5,300,000
Whitehead Institute for Biomedical Research 5,100,000
Massachusetts Eye & Ear Infirmary 4,900,000
Forsyth Dental Center 4,800,000
Center for Blood Research 3,500,000
Joslin Diabetes Clinic 3,500,000
Boston City Hospital 3,100,000
New England Deaconess Hospital 2,700,000
University Hospital 2,700,000
TOTAL $ 322,800,000
NOTE: These figures include research grants only. Training
grants, contracts, and fellowships are not included.
SOURCE: National Institutes of Health
Research Grant Directory 1985
Thomas J. Andrews 1987
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2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
TABLE 4
NIH RESEARCH GRANTS--FISCAL 1985
EXTRAMURAL GRANTS RANKED BY STATE
Rank State $ in millions Rank
California
New York
Massachusetts
Pennsylvania
Texas
Illinois
Maryland
North Carolina
Washington
Connecticut
519.1
504.5
382.6
214.2
173.8
128.2
117.4
108.9
101.3
100.0
All Other
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
State $ in millions
Ohio
Minnesota
Michigan
Missouri
Wisconsin
Tennessee
Florida
Virginia
Colorado
Alabama
93.6
87.1
85.9
77.2
69.6
62.1
50.3
50.0
49.3
48.0
States 444.0
Total NIH Extramural R & D Expenditures $ 3,466,800,000
NOTE: These figures include research grants only. Training
grants, contracts, and fellowships are not included.
SOURCE: National Institutes of Health
Research Grants Directory 1985
Thomas J. Andrews 1987
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7.
8.
9.
10.
BETH ISRAEL HOSPITAL
Beth Israel Hospital is a 449-bed not-for-profit
general hospital located on Brookline Avenue in Boston's
Longwood Medical Area. A teaching affiliate of the Harvard
Medical School, Beth Israel received nearly $10 million in
NIH research grants in 1985, fifth-highest among Boston
hospitals. Its investigators operated out of a cramped
50,000 square-foot facility until 1982, when the hospital
doubled its research space with a new building. The
additional space became fully occupied within a relatively
short time.
At this writing the hospital is constructing a 30,000
square-foot research facility in a two-story building that
abuts the BIH campus. The building's owner, Emmanuel
College, has signed a ten-year lease with the hospital.
Beth Israel has hired a contractor to build out the
improvements, which will be funded internally. At the same
time, the hospital has plans to construct an additional
30,000 square feet of research space in four stories atop an
existing hospital building. Dubbed "Research West", that
space is expected to come on line in 1990, and will give BIH
a total of 160,000 gross square feet of building area
devoted to biomedical research. The hospital expects to
issue $10-12 million in debt to help fund the new facility,
and has already applied to HHS for a deviation from the
interest reimbursement exclusion.
The hospital's administration is confident that they
will not have to expand off-campus in the foreseeable
future. The Director of Research, Joan Pinck, expressed two
major concerns about moving research away from the main
campus. First is the fact that many of the researchers also
have patient care and teaching responsibilities at the
hospital, and they do not wish to spend time travelling to
and from remote facilities. Secondly, there are costs and
inefficiencies associated with off-site research space
because certain ancillary services and facilities (for
example, animal storage) would have to be duplicated at each
site, and transportation would have to be provided for both
employees and research supplies (like tissue samples,
etc.). Ms. Pinck noted that utilization of the abutting
Emmanuel College campus is a possible solution for future
space needs. Emmanuel College has suffered declining
enrollments in recent years.
BRIGHAM & WOMENS HOSPITAL
Brigham & Womens Hospital, with 720 beds, became the
the second-largest hospital in the city when it was formed
in 1980 through the merger of three adjacent institutions.
BWH is a not-for-profit teaching affiliate of the Harvard
Medical School. Situated on Francis Street at the southern
end of the Longwood Medical Area, it encroaches more closely
on the abutting Mission Hill neighborhood than the other
institutions in the area. With a 1987 research budget of
some $50 million, 80% of which is funded by the National
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Institutes for Health, BWH is the number one NIH grantee
among hospitals in the country. All of the hospital's
research space is housed on its Francis Street campus.
In 1985, the sixteen-story, 180,000 square foot George
W. Thorn Research Tower was completed, under a novel
arrangement between three institutions: the Brigham &
Womens, which occupies nine and a half floors, Harvard
Medical School, which occupies four floors, and the Howard
Hughes Medical Institute, which occupies the remaining two
and a half floors. Each floor of the $28 million tower is a
condominium unit. The condominium owners rent the ground on
a 40-year lease from the hospital.
Harvard and the Hughes Institute paid for their six and
a half units with cash from their endowments. The hospital
did not have that option because of covenants related to
debt issued for the earlier construction of a new inpatient
building. For this reason, and because OMB reimbursement
regulations would have precluded recovery of interest costs,
additional borrowing was out of the question. The hospital
considered issuing tax-shelter limited partnerships, but
abandoned that idea when uncertainties about tax reform
arose.
The institution finally settled on an unusual lease
arrangement. Hospital counsel set up an unaffiliated
nonprofit foundation to own the nine and a half condominium
units. The directors of BioSciences Research Foundation
were recruited from other research institutions in the
53
community, to satisfy the "arms-length" requirement in the
OMB regulations. The Foundation then approached a long-term
lender, Aetna Life Insurance, to secure construction and
permanent financing on the basis of the hospital's intention
to lease the nine and a half floors. Aetna agreed to a
thirty-year self-amortizing mortgage. Because their only
security was a portion of a limited use building and the
hospital's promise to pay rent on same, the lender demanded
an additional return. The borrower was required to take
down the full amount of the permanent mortgage at the start
of construction. This amount was escrowed, costing the
hospital more than $1 million in negative arbitrage during
the construction period. As further protection for the
permanent lender, Bank of New England provided a letter of
credit to cover construction cost overruns. According to
Jim Sweeney of the Bank, it was crucial that the project be
completed on time and on budget because the borrower was a
shell foundation. A reliable contractor, George B. Macomber
& Company, was hired and fully bonded. Bank engineers
closely monitored the construction, which proceeded smoothly
to completion.
The hospital's lease with the foundation is set up so
that rent charged is roughly equal to the mortgage payments.
A slight overage from the rental payments is distributed
among the research institutions from which the foundation
directors are drawn. The hospital is able to recover full
reimbursement from NIH for its lease payments, and generates
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a nominal incremental cash flow through the ground lease.
Additional research space for BWH investigators is
being built as needed in the old Boston Lying-In Hospital on
Longwood Avenue, which was acquired as part of the 1980
merger. Renovation costing $150/square foot is in process
for some 40,000 square feet, with an additional 30,000
square feet likely to follow. These renovations are being
funded out of hospital capital reserves. The hospital
intends to seek approval from the Boston Redevelopment
Authority in 1988 for a 180,000 to 200,000 square foot
research facility on the site of an obsolete building on
campus. If this growth occurs as planned, the hospital
could have nearly 350,000 gross square feet of building area
dedicated to biomedical research by 1992.
While acknowledging that a significant portion of the
research done on the Francis Street campus could actually be
done off-site, Vice President for Administrative Services
John Cupples stated that it was "highly preferable" to
maintain all research facilities on the hospital grounds.
He spoke very favorably of the three-party ownership
arrangement, indicating that a great deal of
"cross-pollenization" occurs when investigators from
different institutions can talk to each other in the
corridors or over lunch. Additionally, some economies of
scale are realized through the sharing of storage and other
support areas by the three partners. Cupples noted another
benefit of the condominium building: if the Hospital has a
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short-term surplus of lab space due to a grant expiration,
the Medical School could lease the space, or vice versa.
Like his colleagues at other Boston teaching hospitals,
BWH's Vice President was confident that research volume
would continue to grow in the future. He foresaw the
premier research hospitals, such as BWH, getting a bigger
piece of the NIH pie, as well as expanding into potentially
profitable research partnerships with academia and the
commercial biotechnology industry.
CHILDREN'S HOSPITAL
Children's Hospital, located on 8 acres off Longwood
Avenue in the heart of the Longwood Medical Area, is one of
the premier institutions in the world specializing in
pediatric inpatient care. The 339-bed Harvard teaching
hospital is in the midst of a major upgrading, with an
entirely new inpatient building under construction. Also on
campus is the 178,000 square foot Enders Research Building,
which opened in 1970. The Children's was the fourth-largest
NIH grantee among hospitals in 1986, with a total research
budget of some $27 million. The budget has grown at an
average real annual rate of 2.5% over the past decade. To
keep up with this growth, the hospital is planning an
addition to the Enders building which will roughly double
its size. This addition, scheduled to open in early 1990
with construction costs of $200/square foot, is funded
internally through the hospital's endowment and through a
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major gift campaign. Additional funds for construction were
secured in the form of a capital lease prepayment by the
Howard Hughes Medical Institute, whose researchers will
occupy 30,000 square feet of the completed building.
Because on-campus research space will nearly double
when the new facility comes on line in 1990, Children's
Hospital does not anticipate moving any research off-campus
in the foreseeable future. According to the Long Range Plan
for the Hospital's PDA (Planned Development Area), submitted
to the Boston Redevelopment Authority in April 1987:
The three activities which are central to Children's
mission -- inpatient care, research, and education
-- and intimately linked must remain on the central
campus. As other uses are decentralized and
research expansion projects are completed, there
will be room for internal expansion without
requiring major new construction for a number of
years.
The Vice President of Children's, Carol Weinrib,
surmised that opportunities for private developers to
produce research space for hospitals could occur if three
conditions existed:
1. The institution in need of space has limited options
for its own property because of zoning or F.A.R.
constraints.
2. The institution has limited access to capital at the
time.
3. The developer is able to create an attractive
facility with enough critical mass to keep the
researchers from feeling isolated or segregated from
the institutional mainstream.
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DANA-FARBER CANCER INSTITUTE
The Dana-Farber Cancer Institute, situated on Binney
Street in the heart of the Longwood Medical Area, is one of
the leading centers in the world for the diagnosis,
treatment, and study of cancer. The Institute's researchers
received over $25 million in NIH grant monies in 1985, of a
total research budget of over $30 million. With the study
of cancer as its primary mission, DFCI operates only 57
patient beds. The Institute's commitment to continued
leadership in cancer research is embodied in the new Mayer
Building, a 9-story, 120,000 square-foot structure now being
built at a cost of $24 million. The entire building will be
occupied by research labs, adding to the 165,000 existing
square feet at the Institute. Director of Research Dr.
Bernard Janicki says the new space will alleviate a severe
overcrowding condition and allow for recruitment of some new
research faculty.
Janicki stated that it was unlikely that DFCI research
facilities would ever be built away from the main campus.
The Institute's researchers all have clinical and teaching
responsibilities in the Longwood Medical Area, and DFCI
itself has research and clinical interrelationships with
several of the other Longwood Area hospitals. For example,
one of New England Deaconess Hospital's cancer treatment
facilities is located in a DFCI building, and the Cancer
Institute's pediatric oncology department is housed at the
Children's Hospital.
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NEW ENGLAND DEACONESS HOSPITAL
New England Deaconess Hospital is a 489-bed Harvard
teaching hospital located in the Longwood Medical Area.
With 56,000 square feet of research space in two on-campus
facilities, the Deaconess recently made an institutional
commitment to upgrade its teaching and research reputation,
a commitment that would require more and better lab space.
At the same time, the hospital was facing the need to
substantially renovate its aging patient care facilities.
The huge capital requirements of the bed replacement forced
the hospital to a less capital-intensive solution for its
research needs. Furthermore, the physical constraints of
the NEDH campus demanded that new research facilities be
created off-site.
To solve its research space problem, the hospital
entered into an agreement with a local contractor, Kennedy &
Rossi Inc., specialists in laboratory construction. K & R
leased 20,000 gross square feet of shell space in a
warehouse near Kenmore Square that happened to be owned by
Children's Hospital. The space was built out to NEDH's
specifications by K & R, then subleased to the hospital at a
rate which covered all of K & R's construction and carry
costs, and profit. All operating expenses are paid by the
hospital, as are any expense pass-throughs (such as tax
escalations), that K & R has to pay under its lease from
Children's. The lease and the sublease each run for ten
years, as does the bank financing that K & R arranged for
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all the hard and soft costs. Hospital researchers occupied
the space in late 1986.
The hospital's Director of Research, Robert Pence, is
pleased with the arrangement, although he acknowledges that
the rental rate is expensive. But because 70% of NEDH's
research dollars come from the federal government, with full
reimbursement for operating lease expenditures, most of
those costs are being recovered. Even if the land and debt
capacity had been available for Pence to build a new
research facility on campus, the hospital would have been
unable to recover interest payments as part of their
indirect cost reimbursement for research grants.
Furthermore, OMB reimbursement guidelines require the
depreciation allowance to be calculated on a building finish
useful life of twenty years, whereas with the lease the
construction cost is essentially amortized over the ten-year
term, thus allowing significantly higher reimbursements.
The hospital also had the benefit of having the facility up
and running more quickly than had it petitioned for the
interest reimbursement waiver and tried to build the
facility itself. Charged with upgrading the institution's
research reputation, Pence needed space in a hurry in order
to begin attracting qualified people.
As for the facility's location one mile from the
hospital's main campus, considerable grumbling from those
being transferred had to be endured by the hospital
administration, and shuttle transportation had to be
provided for the research staff. However, once routines
became established, people began to acknowledge that the
inconvenience was only minor. Also, because the remainder
of the building was occupied by NEDH ancillary departments
such as Accounting and Data Processing, the research labs
were not completely isolated from hospital activity.
Research Director Pence is sufficiently satisfied with the
arrangement to be looking for another lease opportunity, as
the Kenmore Square space is now fully occupied. He
estimates an additional requirement of 65,000-130,000 square
feet over the next 5-10 years.
NEW ENGLAND MEDICAL CENTER HOSPITAL
The New England Medical Center campus is located in the
densely residential Chinatown neighborhood near downtown
Boston. NEMC Hospital is a 416-bed teaching hospital
affiliated with the Tufts University School of Medicine.
The NEMC Hospital had a research budget of $25.5 million
(70% from the federal government) in 1987, up from $12
million in 1982.
In 1984, the hospital was utilizing 60,000 square feet
of extremely cramped lab space. The decision to expand had
been made, but little capital was available from the
hospital's endowment. The Medical Center fielded offers
from developers for the turn-key construction and lease-back
of off-site research facilities, but few of the firms had
the requisite experience in the development of such
facilities. Funds for expansion suddenly appeared when a
grateful, and wealthy, former patient expired and left some
$10 million to the hospital. NEMC promptly converted the
14-story, 60-year-old garment factory at 25 Kneeland Street
into the Tupper Research Institute. The 100,000 square foot
facility, which the hospital had purchased earlier because
of its strategic location on the edge of campus, was
renovated at a cost of $165 per gross square foot.
The Tupper gift came just at the right time for the
hospital. Although Director of Research Administration
Frank Stout says, "We really don't want to work with anyone
we don't have to (ie., outside developers)", he acknowledged
that NEMC might have had to solve its space squeeze by
leasing turn-key space from a developer. With researchers
now moved into the newly renovated facility, the hospital is
renovating the older laboratories in the Ziskind Building to
bring all its facilities up-to-date. Funding is being
generated through a four-year $24 million gift campaign.
To assure that the costs of medical research are
covered adequately by the reimbursement dollars received,
NEMC uses stringent internal productivity standards for lab
space allocation. Each research department must generate
$200 of direct cost reimbursement per net square foot of lab
space utilized. Thus, if the Neurology department occupies
10,000 net square feet of labs, it must generate at least $2
million in direct reimbursement or it may be required to
relinquish lab space to another, more productive department.
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TUFTS UNIVERSITY SCHOOL OF MEDICINE,
SCHOOL OF DENTAL MEDICINE,
SCHOOL OF GRADUATE BIOMEDICAL SCIENCES
Tufts' health sciences divisions are housed in several
buildings abutting the NEMC campus in Chinatown. The
university's 1986 research budget was about $38 million,
some $12 million of which was directed to the US Department
of Agriculture's Human Nutrition Research Center, which is
operated by Tufts. Of the remaining $26 million, 80% is
funded by the federal government. Although budget growth
was flat in 1986, research funds had expanded at a rate of
over 15% per year for the previous four years. This growth
has saturated the 100,000 net square feet of existing
laboratory space which is scattered throughout the complex
of renovated older buildings at 136 Harrison Avenue.
Dr. Joseph Byrne, Associate Provost for Research,
described plans for an additional 70,000 net square feet of
research space by 1992. A large chunk of this would be
housed in the so-called "Infill Building" that would fill in
the horseshoe-shaped complex at 136 Harrison. Dr. Byrne
said the School's long-range plans call for a total of
250,000 net square feet dedicated to research by 1997.
The University has kicked off a five-year capital
campaign to help finance the planned expansions. Dr. Byrne
anticipates that the Infill Building would be funded
one-third by borrowing and one-third by donations, and that
the remaining capital could be secured from the federal
government in the form of a direct construction grant.
Although the NIH has issued very few capital grants
recently, Tufts' adminstration is confident that funds will
soon come available and that the School of Medicine will be
able to access those funds.
When asked if leased facilities were a viable
alternative for the School, Dr. Byrne responded that the
option would certainly be considered if sites could be found
within walking distance to the main campus. Investigators,
he noted, usually have teaching responsibilities at the
School and clinical responsibilities next door at NEMC.
They would be very reluctant to venture too far off-site to
reach their laboratories.
BOSTON UNIVERSITY SCHOOL OF MEDICINE
UNIVERSITY HOSPITAL
Boston University Schools of Medicine and Graduate
Dentistry and University Hospital share a campus on the
fringe of the city's South End neighborhood. The Schools
and University Hospital had 1985 research grants of nearly
$35 million from NIH, most of that assigned to the School of
Medicine. This figure represents some 80% of the total
research budget for the institutions. University Hospital,
a 379-bed teaching facility which is affiliated with but not
owned by the School, is nearing completion of a $66 million
reconstruction of its patient care buildings. The School of
Medicine has about 180,000 square feet of research space
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scattered throughout its campus.
BUSM has leased research space in the past from the
state's Department of Mental Health, which operates a
building next door to the School of Medicine. This
favorable experience led the school's Dean, Dr. John Sandson
to choose the lease option when expansion space was needed
in 1987. The School has entered into an agreement with
Community Development Corporation of Boston, a non-profit
developer, to lease 37,000 square feet of shell space on the
top three floors of 801 Albany Street, a five-story building
located a few blocks from the main campus. The 60-year-old
former paint brush factory had been sold below cost to CDC
of Boston. Since the structure is in an economically
disadvantaged neighborhood, a package of federal, state, and
city loans and guarantees will supplement the bank loan for
the improvements. The five-year lease has three five-year
options, and calls for the School to build out the
improvements. As an educational institution, not a
hospital, BUSM can recoup its interest costs from the
federal government should it choose to borrow money to
construct the laboratory space.
Dean Sandson estimates that the School of Medicine will
require another 50,000 square feet of research space within
the next five years. Because the existing campus will not
support any further development, it seems likely that the
school will be looking for space around the perimeter of its
property in the South End.
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MASSACHUSETTS GENERAL HOSPITAL
Massachusetts General Hospital, with 1082 beds, is the
largest hospital in New England, both in terms of total
budget (nearly $400 million in 1987) and in research
expenditures ($75 million). The institution, which is
affiliated with the Harvard Medical School, occupies a
densely built campus in the West End of Boston, facing the
Charles River. MGH broke ground in 1987 for the first of
two new, and long-delayed, patient care towers costing $250
million. The Hospital devotes nearly 290,000 square feet on
campus to biomedical research, and early in 1987 reinforced
that commitment by signing a substantial long-term lease in
Building 149 at the former Charlestown Navy Yard.
Of the $75 million budgeted for research, 55% is from
the federal government, 17% from foundations, 10% from the
endowment, and 18% from commercial contracts. The
percentage of commercial funding has increased dramatically
in recent years as research breakthroughs at the hospitals
began to show market promise. The Hospital aggressively
requires all its funding sources to reimburse the
institution for indirect costs at the overhead rate
established by OMB. Any exeptions to this policy have to be
reviewed by the Hospital Board of Directors. The policy
attempts to ensure that research operations are not
subsidized by patient care revenues, a situation that would
be unacceptable to third party payors and which conflicts
with the institution's primary mission as a care provider.
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The Charlestown Navy Yard, closed by the Nixon
Administration in 1974 and turned over to the Boston
Redevelopment Authority (BRA), is being redeveloped into
housing, offices, and other uses by private developers
designated by the BRA. Building 149, a ten-story, 650,000
square foot former warehouse, had been renovated into
speculative office space by the Congress Group, a private
developer. When many months passed with no office leases
consummated, the Congress Group sold its interests in
Building 149 and its neighbor, Building 199 (which had been
made into a 1400-car garage), to a group headed by Neil St.
John Raymond, an established Boston developer.
Raymond planned to create an enormous medical research
center at Building 149. Before closing on the sale of the
two buildings, Raymond secured a lease commitment from MGH.
If all options are exercised, it will be the most valuable
lease ever executed in the city of Boston. Raymond says
that his group, which has considerable equity in the
project, is essentially acting as a lender to the
institution. He felt that the hospital could have purchased
Building 149 had it chosen to, but that by selecting the
lease option MGH was practicing prudent "fiscal
conservatism".
According to Lawrence Martin, Assistant General
Director of the Hospital, the lease solved three separate
problems for MGH. First, the institution's computer
operations were in two different locations on campus and
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needed to be consolidated. The same was true of the offices
of the fiscal affairs department. Some 92,000 square feet
at Building 149 was reserved for these two departments.
Third, MGH's researchers were crammed into an average of
about 200 square feet of research space per person. The
Wellman Research Building, which opened in 1984, had filled
up quickly, and now some investigators were applying for
continuations from their sponsors because no lab space was
available in which to start their experiments.
The lease between MGH and Biotechnology Research
Associates, Inc., is for 175,000 square feet (92,000 square
feet office and computer, to be occupied in September 1987;
and 83,000 square feet research, occupancy January 1988).
An option, to be exercised by March 1988, provides for an
additional 205,000 square feet of research space. At this
writing, Assistant Director Martin reports that the initial
research space, plus three quarters of the option space, has
been subscribed to researchers who are already funded. The
Hospital fully expects to "sell out" the rest of the space
and exercise the option. This enormous space consumption is
somewhat illusory in that researchers at Building 149 are
initially being allocated some 500 square feet per person.
As new researchers.are added, however, Martin expects the
density to settle around a comfortable and efficient 350
square feet per person.
The term of the lease is 15 years with 5 year renewals,
except for the office/computer component, which runs for 10
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years. The rental rate bumps up during the term, and the
Hospital pays for electricity and for escalations over a
base property tax amount. Because the base rental rate is
fixed and incorporates a "standard" level of lab finish, the
hospital administration has set aside a fund to pay for
customized lab spaces. The administration allocates this
money based on institutional research priorities.
Since the Navy Yard is over a mile from the Hospital
campus, many in the medical research community were very
surprised to hear of MGH's major commitment in Charlestown.
Medical research had always been carried out in the heart of
hospital campuses. Even some MGH administrators predicted
extreme difficulty in persuading researchers to relocate to
a remote facility, away from their patient care and teaching
duties. Once the spaciousness and the quality of the new
facility were apparent, however, a few key investigators
agreed to make the move to Charlestown. These respected
individuals provided the critical mass and were followed by
many others who wished to maintain proximity to the most
prestigious research activities.
The competitive advantage for MGH of having extra
research space available was detailed in an article in the
June 1987 Boston Hospital News. Describing a program headed
by Dr. Kurt Isselbacher, Director of the new MGH Cancer
Research Center, which will be housed in Charlestown, the
article stated:
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One of Dr. Isselbacher's major tasks will be to
recruit additional top-flight scientific talent for
the center. He anticipates an almost 30 percent
increase in personnel, now that the availability of
space in Charlestown has made expansion possible.
Many of the new researchers are expected to be young
scientists who already have excellent records of
accomplishment and who can "come on-board" as
quickly as laboratory space is set aside for them.
"The whole excitement is to create an even better
intellectual scientific environment, which in turn
will improve patient care," Dr. Isselbacher said.
Several factors conspired to make the Navy Yard lease
an appropriate solution to MGH's space requirements. First,
$250 million in tax-exempt bonds had been issued by the
Hospital to fund the new patient care towers. Hospital
auditors predicted that the issuance of more debt would
jeopardize the institution's Standard & Poor's AA rating.
Thus, buying or constructing a research building was ruled
out as an option. This stance was fortified by the
Hospital's experience with the Wellman Research Building.
Built with tax-exempt bonds, Wellman drained MGH coffers for
a year when HHS enforced the OMB provision against interest
cost reimbursement and an expected gift fell through. After
protracted negotiations, HHS finally agreed to reimburse for
interest expense, and even agreed to pay double interest
expense for the second year of operation. Nonetheless, an
operating lease arrangement would obviate the need for a
waiver application and lengthy negotiations with the federal
government. Another important factor in MGH's decision was
the opportunity for future expansion at the Navy Yard.
Should Building 149 fill up, Developer Raymond promised to
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convert part of the huge garage, Building 199, to research
space, and beyond that were 14 vacant acres still under BRA
control.
MASSACHUSETTS EYE & EAR INFIRMARY
Massachusetts Eye & Ear Infirmary is a 174-bed Harvard
teaching hospital specializing in eye, ear, nose, and throat
(EENT) care. The Infirmary received 90% of its $6.5 million
1986 research budget from the NIH. Most of MEEI's physical
plant, including about 40,000 square feet of research space,
is contained in a twelve-story building squeezed between the
Suffolk County Jail and the Massachusetts General Hospital
campus. The Infirmary was outbid by MGH in its attempt to
secure the Jail site, which is to be vacated by the County
by 1990. Because of the nearby Beacon Hill and Charles
River Park neighborhoods, expansion options are extremely
limited for the institution. As of this writing,
negotiations are underway for a lease arrangement whereby
MEEI researchers would occupy a portion of Building 149 at
the Navy Yard in Charlestown.
Vice President of Finance Patrick Capobianco explained
the interest in the Charlestown building:
The growth of our research volume has been
constrained for several years by space limitations.
Our investigators are clamoring for more space so
they can apply for more grant money. With NIH
awarding about $200 million per year in EENT
research grants, we feel certain that this
institution can secure a bigger share of that pie.
The Infirmary is seeking an initial 15-year lease of
40,000 square feet at Building 149, with options to roughly
double that amount after three years, and additional options
at subsequent intervals. Capobianco expects that a
diffusion of existing research will fill most of the initial
space. Meanwhile, investigators can begin to prepare
proposals for future research grants knowing that the
additional laboratories will be available in Year 3.
Capobianco noted that the time required for proposal
preparation, submission, and award notification can often
take around two years.
MEEI will attempt to have as much of the cost of
laboratory construction rolled into the lease payment as
possible, since the institution will be fully reimbursed for
the amount of the lease payment by NIH. Any construction
costs that the developer does not roll into the lease
payment would have to be picked up by the Infirmary,
possibly through borrowing, in which case the interest
expense would not be reimbursable without a deviation
procedure.
MEEI administrators were initially concerned about the
distance from the Infirmary to Charlestown, but are
comforted by MGH's success in assembling a critical mass of
research activity at Building 149. The Infirmary now does
not expect any difficulty in persuading investigators to
relocate to the planned new facility in Charlestown.
CASE STUDY SUMMARY
The Boston cases demonstrate that opportunity exists
for developers to service the research space needs of
teaching hospitals and medical schools. Three institutions
have entered into agreements for leased laboratory space,
and a fourth is pending. The presence of one or more of the
following conditions has steered the institutions to the
lease decision. First, the institution is in a competitive
environment. Though some institutions fare better than
others, it is very difficult to make money on research. A
high-quality, expanding research program serves to attract
capable clinicians and enhance the institution's reputation,
which then attracts patients. Second, the institution's
existing campus has no expansion capacity, or the capacity
available is reserved for future patient care facilities.
Most academic medical centers exist on constrained urban
campuses. Finally, there are financial incentives for
leasing. The hospital may be funding a major capital
expansion, and adding new debt would be imprudent or
impossible. The following chapter will demonstrate that
federal reimbursement policies favor leasing turnkey space
over shell space.
A developer who is attempting to build space to suit a
hospital's needs must be cognizant of the delicate position
occupied by the hospital administration. A hospital's
reputation is created in large part by the doctors who treat
its patients. The hospital administration's challenge is to
retain these key people by servicing their needs while still
operating the institution as a business. When a hospital
develops its own new research facilities, schedule is often
a smaller issue than budget. The administration will move
methodically to collect the input of the investigators, many
of whom will have very specific request for customization of
their research spaces. Institutional priorities will then
determine whose requests are met within the realities of the
budget.
Some design professionals interviewed for this paper
suggested that the developer could leverage his position
outside the institution to expedite the design process. The
lease agreement should stipulate realistic time frames for
the collection of user input, with penalty to the tenant if
design time overruns because of difficulties in extracting
input from the investigators who will occupy the space. If
the institution insists on having the design team at its
full disposal, the developer must assure that the costs
associated with this level of service, including costs of
delay in project completion, are borne by the institution.
Chapter XII
FINANCIAL ANALYSIS
Because institutions have traditionally built and owned
all of their facilities, a developer proposing a lease
arrangement should be prepared to offer some financial
justifications to overcome the institution's concerns about
lack of control. The proforma cash flow analyses presented
in Exhibits 1-4 illustrate the impact of the federal cost
reimbursement policies on various occupancy arrangements for
research performers. Exhibit 5 looks at a particular
arrangement from the developer's cash flow statement.
Except for Exhibit 4, the facts for each case are
similar in order to facilitate comparison. Each case
assumes that laboratories are built out in shell space
rented from a taxable entity on a 15-year triple- net lease.
Exhibit 4 shows cash flows for a new building constructed
and held for 15 years by the nonprofit research performer.
All cash flows are assumed to come at the end of each
year, then inflows are netted against outflows. The cash
flows are then discounted back to Time 0 at a discount rate
of 9%. The discounted cash flows result in a net present
cost or net present value at Time 0. For Exhibits 1-4,
these discounted flows are equalized to produce a
Time-Adjusted Annual Cash Flow Equivalent, which is the
15-year annuity which would have same net present cost or
value as the cash flows shown.
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Exhibit 1
HOSPITAL PROFORMA
TURN-KEY SUBLEASE FROM DEVELOPER
This case assumes that the developer signs a 15-year
lease for shell space. The lease is triple-net with small
escalations after Years 5 and 10. The developer approaches
the Director of Research Administration at a medium-sized
teaching hospital and offers to produce a turn-key
laboratory in the shell space after 6 months of
construction. The hospital would have to agree to sign on
for the remaining 14.5 years of the base lease.
The developer has approached a local commercial bank
with whom he has done business before. The bank is
interested in establishing a relationship with the hospital.
The lender, comfortable with the developer's expertise in
lab construction and with the hospital's credit and future
prospects, agrees to finance all of the developer's initial
costs. This includes the base lease payments during the
construction period, all construction costs, and even the
developer's 8% fee. The bank writes a 15-year
self-amortizing mortgage secured by the hospital's ability
to pay rent.
The hospital's rental rate is calculated by adding the
developer's base lease payment to the developer's mortgage
payment, then multiplying by a debt coverage ratio with
which the lender feels comfortable. The hospital would also
be responsible for paying property taxes above the base year
amount.
For ease of illustration the Exhibit assumes that the
all of the hospital's research fund sources are paying full
indirect cost reimbursement, as the NIH would. Under OMB
guidelines, the hospital's operating lease payments for its
research facility qualify as reimbursable indirect costs of
supporting research. The hospital would be reimbursed
periodically for its lease payments. Thus, under this
scenario, the hospital's cash position is completely
neutral.
The biggest drawback from the hospital's perspective
would be the loss of control of the space at the end of the
term. There is also the risk of major upheavals in the
research funding environment. For example, because property
tax and developer profit are rolled into the hospital's
lease payment, the institution will likely be at the higher
end of the indirect cost percentage spectrum. Should OMB
decide to cap indirect cost rates, or award grants with
consideration for cost efficiency, the hospital's research
program could suffer.
EXHIBIT 1
ASSUNPTIONS--TURN-KEY SUBLEASE FROM DEVELOPER
LEASE TERNS--DEVELO
Developer lease (GSF)
Lease term (yrs)
Lease rate ($/GSF/yr) Yr 1-5
% Bump (Yr 6, 11)
Lease start date
Lease end date
Property tax rate ($/GSF/yr) Yr 1
Property tax rate ($/GSF/yr) Yr 2-4
Property tax bump (%) Yr 5,8,11,14
PROJECT COSTS
Hard project costs
Soft project costs (not incl interest)
Major movable equipt costs
Total construction costs
Developer's fee () 8.00
Total project costs
PER
20,000
15
$5.00
10.0%
Time 0
Time 15
$1.25$2.50
15.00%
$/GSF TOTAL
$105.00 2,100,000
20.00 400,000
25.00 500,000
150.00 3,000,000
% 12.00 240,000
$162.00 3,240,000
CONSTRUCTION/PERIANENT LOAN
Developer loan term (yrs) 15
Developer dovnpayment 0.0%
Construction period (montbs) 6
Constr. per. ave. bal. (% of tot. cost) 50%
Interest rate (annual %) 9.5%
Total costs 3,240,000
Less: downpayment 0 -
Total costs to be financed
Construction period interest
Construction period rent
Developer loan principal
Loan payment (annual)
Debt coverage ratio
3,240,000 =
76,950 +
50,000 +
3,366,950
$430 1071.15
Hospital
Hospital
Sublease
Sublease
Property
HOSPITAL SUBLEASE
sublease (GSF)
sublease term (yrs)
start date
end date
tax allowance ($/GSF/yr)
Time
Time
Hospital lease rate (first 4.5 yrs)
DC ratio I (loan payt + lease payt)
Lease rate (next 5 yrs)
Lease rate (last 5 yrs)
HOSPITAL INCOME
Lab opening date
Research volume ($/GSF/yr) Yr I
Research volume ($/GSF/yr) Yr 2
Research volume ($/GSF/yr) Yr 3
Research voluse growth %/yr) Tr
Full reimbursement %
Discount rate ()
Time
s 4-15
20,00014.5
0.5
15$2.50
ANNUAL
$/GSF TOTAL
30.48 609,623
31.06 621,123
31.69 633,773
0.5
100.00
$120.00$150.00
5.0%
100.0%
9.0%
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Exhibit 2
HOSPITAL PROFORMA
HOSPITAL LEASES SHELL, BUILDS IMPROVEMENTS
INTEREST COSTS NOT RECOVERABLE
The scenario depicted in Exhibit 2 assumes that the
hospital has gone directly to the owner of the shell space
and secured a 15-year lease agreement exactly like the one
the developer secured in the previous Exhibit. Once again,
construction will require a period of 6 months, during which
base lease payments and property taxes are due.
Unlike the developer, the hospital will not fully
leverage the project. The 25% downpayment is assumed to be
drawn from the endowment or cash reserve. If the
downpayment was generated through a gift campaign, it could
be argued that the financial analysis should not consider
that a cash outflow.
The hospital's reimbursement is calculated by
depreciating the building finish over the term of the lease,
equipment over 8 years, and adding those allowances to the
base lease and property tax payments. Because of the
initial cash outflows and the lack of interest recovery,
cash flow is substantially negative in the early years of
the lease. This is not a favorable arrangement from the
hospital's perspective.
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EXHIBIT 2
ASSUMPTIONS -- HOSPITAL LEASES SHELL, BUILDS INPROVEMENTS
INTEREST COSTS NOT RECOVERABLE
LEASE TERNS--HOSPITAL
Hospital lease (GSF) 20,000
Lease term (yrs) 15
Lease rate ($/GSF/yr) Yr 1-5 $5.00
% Bump (Yr 6, 11) 10.0%
Lease start date Time 0
Lease end date Time 15
PROJECT COSTS $/GSF TOTAL
Building shell costs $0.00 0
Building finish costs 125.00 2,500,000
Major movable equipt costs 25.00 500,000
Total costs (not incl. interest) 150.00 3,000,000
CONSTRUCTION/PERKANENT LOAN
Hospital loan term (yrs) 15
Hospital downpayment (%) 25%
Construction period (months) 6
Constr. per. ave. bal. (% of tot. cost) 50%
Interest rate (annual %) 9.5%
Total costs 3,000,000
Less: Downpayment 750,000 -
Total costs to be financed 2,250,000 =
Construction period interest 53,438 +
Construction period rent 50,000 +
Hospital loan principal 2,353,438
Loan payment (annual) 305,525
USEFUL LIVES
Building shell useful life (yrs) n/a
Building finish useful life (yrs) 15.0
Major movable equipt useful life (yrs) 8
PROPERTY TAXES
Property tax rate ($/GSF/yr) Yr 1 $1.25
Property tax rate ($/GSF/yr) Yr 2-4 $2.50
Property tax bump (%) Yr 5,8,11,14 15.0%
HOSPITAL INCOME
Lab opening date Tim 0.5
Research volume ($/GSF/yr) Yr 1 $100.00
Research volume ($/GSF/yr) Yr 2 $120.00
Research volume ($/GSF/yr) Yr 3 $150.00
Research volume grovth (%/yr) Yrs 4-15 5.0%
Full reimbursement % 100.0%
Discount rate 9.0%
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Exhibit 3
HOSPITAL PROFORMA
HOSPITAL LEASES SHELL, BUILDS IMPROVEMENTS
INTEREST COSTS RECOVERABLE
Exhibit 3 shows the results of successful negotiation
with the HHS auditor over the allowability of interest
payments as an indirect cost. Because the interest expense
is now being reimbursed, there are actually some positive
annual cash flows during the first half of the lease. Both
the hospital and the hospital's lender will be more
comfortable with this arrangement.
One cause for concern here is the fairly high indirect
cost rate during the early years, which could be problematic
if research sponsors attempt to trim their costs in the
future.
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EXHIBIT 3
ASSUMPTIONS -- HOSPITAL LEASES SHELL, BUILDS INPROVENENTS
INTEREST COSTS RECOVERABLE
LEASE TERNS--HOSPITAL
Hospital lease (GSF) 20,000
Lease term (yrs) 15
Lease rate (S/GSF/yr) Yr 1-5 $5.00
% Bump (Yr 6, 11) 10.0%
Lease start date Time 0
Lease end date Time 15
PROJECT COSTS $/GSF TOTAL
Building shell costs $0.00 0
Building finish costs 125.00 2,500,000
Najor movable equipt costs 25.00 500,000
Total costs (not incl. interest) 150.00 3,000,000
CONSTRUCTION/PERNANENT LOAN
Hospital loan term (yrs) 15
Hospital downpayment (%) 25%
Construction period (months) 6
Constr. per. ave. bal. (% of tot. cost) 50%
Interest rate (annual %) 9.5%
Total costs 3,000,000
Less: Downpayment 750,000 -
Total costs to be financed 2,250,000 =
Construction period interest 53,438 +
Construction period rent 50,000 +
Hospital loan principal 2,353,438
Loan payment (annual) 305,525
USEFUL LIVES
Building shell useful life (yrs) n/a
Building finish useful life (yrs) 15.0
Najor movable equipt useful life (yrs) 8
PROPERTY TAXES
Property tax rate ($/GSF/yr) Yr 1 $1.25
Property tax rate ($/GSF/yr) Yr 2-4 $2.50
Property tax bump (%) Yr 5,8,11,14 15.0%
HOSPITAL INCONE
Lab opening date Time 0.5
Research volume ($/GSF/yr) Yr 1 $100.00
Research volume ($/GSF/yr) Yr 2 $120.00
Research volume ($/GSF/yr) Yr 3 $150.00
Research volume growth %/yr) Yrs 4-15 5.0%
Full reimbursement % 100.0%
Discount rate 9.0%
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Exhibit 4
HOSPITAL PROFORMA
HOSPITAL CONSTRUCTS BUILDING
INTEREST COSTS RECOVERABLE
The scenario shown in Exhibit 4 differs in several ways
from the shell leases discussed above. Because the
structure is built and owned by a non-profit entity, no
property taxes are assumed. In reality, the institution may
be expected to make a payment in lieu of taxes to the
municipality. As a new construction project, it will be one
year from Time 0 before occupancy can occur. Once again the
institution will put down 25% of the project cost, which of
course is higher ($200/sf) because it is new construction.
Because of the interest cost recovery, cash flows are
positive in the early years of the holding period. This
occurs despite the relatively small useful life allowances
on the building's shell (1/40 per yr.) and finishes (1/20
per yr.). The reason for the large, positive Net Present
Value to the hospital is the assumption about appreciation
of the asset. Unlike the lease scenarios detailed above, in
this case there is a residual at the end of the holding
period. This analysis assumes that the building's shell has
appreciated by 9% per year over the holding period, and the
finishes have depreciated on a straight-line basis over
their 20-year useful life.
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ASSUMPTIONS --
EXHIBIT 4
HOSPITAL
INTEREST
Building area (GSF)
Holding period (yrs)
CONSTRUCTS BUILDING
COSTS RECOVERABLE
20,000
15
PROJECT COSTS S/GSF TOTAL
Building shell costs 50.00 1,000,000
Building finish costs 125.00 2,500,000
Najor movable equipt costs 25.00 500,000
Total costs (not incl. interest) 200.00 4,000,000
CONSTRUCTION/PERHANENT LOAN
Hospital loan tern (yrs) 15
Hospital downpayment (%) 25%
Construction period (months) 12
Constr. per. ave. bal. (% of tot. cost) 50%
Interest rate (annual %) 9.5%
Total costs 4,000,000
Less: Downpayment 1,000,000 -
Total costs to be financed 3,000,000
Construction period interest 142,500 +
Hospital loan principal 3,142,500
Loan payment (annual) 415,024
USEFUL LIVES
Building shell useful life (yrs)
Building finish useful life (yrs)
Najor movable equipt useful life (yrs)
HOSPITAL INCOE
Lab opening date
Research volume ($/GSF/yr) Yr
Research volume ($/GSF/yr) Yr
Research volume (S/GSF/yr) Yr
Research volume growth (%/yr)
Full reimbursement %
Time
5-15
Property appreciation rate (shell)
Discount rate
40
20
8
1$110.00
$120.00$150.00
5.0%
100.0%
9.0%
9.0%
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Exhibit 5
DEVELOPER PROFORMA
TURN-KEY SUBLEASE
Exhibit 5 shows the cash flow to the developer for the
turn-key sublease deal described under Exhibit 1. Because
the developer is 100% financed including the development
fee, this arrangement carries an infinite return. This
analysis does not even take into account the tax advantages
that will occur because of interest and depreciation charges
against the rental income. With a credit tenant like the
hospital in place, the developer could easily sell the
income stream if he needed to take extra cash during the
term of the lease.
Further examination of potential financial returns to
developers is beyond the scope of this paper. The case
studies presented earlier suggest that superior financial
returns are available to developers in build-to-suit
long-term lease situations. The selection of a stable
institution with a commitment to research and an ability to
compete for funding is imperative. The developer must then
structure the deal to minimize his construction, financing,
and operating cost risks.
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EXHIBIT 5
ASSUMPTIONS--TURN-KEY SUBLEASE
LEASE TERMS-
Developer lease (GSF)
Lease term (yrs)
Lease rate ($/GSF/yr) Yr 1-5
% Bump (Yr 6, 11)
Lease start date
Lease end date
Property tax rate ($/GSF/yr)
Property tax rate ($/GSF/yr)
Property tax bump (%) Yr 8
PROJECT COSTS
Hard project costs
Soft project costs (not incl
Major movable equipt costs
Total construction costs
Developer's fee (%)
Total project costs
-DEVELOPER
Yr 1
Yr 2-4
,11,14
20,000
15
$5.0010.0%
Time 0
Time 15$1.25
$2.50
15.00%
S/GSF TOTAL
$105.00 2,100,000
interest) 20.00 400,000
25.00 500,000
150.00 3,000,000
8.00% 12.00 240,000
$162.00 3,240,000
CONSTRUCTION/PERMANENT LOAN
Developer loan term (yrs) 15
Developer downpayment 0.0%
Construction period (months) 6
Constr. per. ave. bal. (% of tot. cost) 50%
Interest rate (annual %) 9.5%
Total costs 3,240,000
Less: downpayment 0 -
Total costs to be financed
Construction period interest
Construction period rent
Developer loan principal
Loan payment (annual)
Debt coverage ratio
HOSPITAL SUBLEASE
Hospital sublease (GSF)
Hospital sublease term (yrs)
Sublease start date
Sublease end date
Property tax allowance ($/GSF/yr)
3,240,000
76,950 +
50,000 +
3,366,950 =
$430 1071.15 x
Time
Time
Hospital lease rate (first 4.5 yrs)
DC ratio X (loan payt + lease payt)
Lease rate (next 5 yrs)
Lease rate (last 5 yrs)
Discount rate ()
20,00014.5
0.5
15$2.50
ANNUAL
$/GSF TOTAL
30.48 609,623
31.06 621,123
31.69 633,773
9.0%
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Chapter XIII
CONCLUSIONS
This paper set out to examine a small niche of the real
estate market, the biomedical research facility. Because of
the narrow market and the nature of the institutional users,
the development industry has in the past been under-
represented in the production of medical research space.
Demand for research space is driven by the availability
of funds from government, industry, or philanthropies. Each
sector has demonstrated a commitment to research support in
the past. Future prospects for funding levels are at least
fair and might be very good under certain political
and economic conditions.
Academic research performers throughout the country are
intent on fulfilling their research mission by remaining
competitive for funding. To achieve this end, many will
seek to upgrade or expand their facilities.
Opportunities for the development community to produce
laboratory facilities for research institutions could occur
if certain conditions exist:
1. Institutional growth is constrained by campus density and
surrounding competing uses.
2. The institution is unable or unwilling to secure
construction funds.
3. Occupancy cost reimbursement by the institution's
research sponsors allows recovery of leasing costs.
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4. The institution is able, if necessary, to persuade its
investigators to perform their research at a site which
is not immediately adjacent to the sites of their
teaching and clinical duties.
Because of the specialized nature of the product, and
the difficulty of the planning and design process, a
developer who establishes a level of skill in producing
these facilities will probably be faced with few competitors
in a given market. Prudent deal structuring should result
in excellent financial returns to the developer.
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